FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, namely to the transversal suspension subline kidney cells of the newborn Syrian hamster BHK-21/SUSP/ARPJAH. Cell line is intended for reproduction of foot-and-mouth disease virus, rabies, parainfluenza-3, Aujeszky's disease in the production of antiviral vaccines, as well as for making diagnostic and preventive veterinary biopreparations and deposited in the Specialized collection of cell cultures of the Core facilities centre "Collection of vertebrate cell cultures" of the Institute of Cytology of the Russian Academy of Sciences on April 23, 2019 under number RKKK(P) 797 D.
EFFECT: invention widens the range of equipment.
8 cl, 11 dwg, 6 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
FMD CULTURE INACTIVATED SORBED VACCINE FROM A/AFGHANISTAN/2017 STRAIN OF A/ASIA/IRAN-05FAR-11 NEW GENOTYPE | 2022 |
|
RU2798293C1 |
CULTURE INACTIVATED SORBED VACCINE AGAINST FOOT AND MOUTH DISEASE OF O/ME-SA/PanAsia2 GENOTYPE FROM O N2356/PAKISTAN/2018 STRAIN | 2023 |
|
RU2810131C1 |
INACTIVATED SORBED VACCINE AGAINST FMD OF O/EA-2 GENOTYPE FROM O/KENYA/2017 STRAIN CULTURE | 2023 |
|
RU2802192C1 |
CULTURALLY INACTIVATED SORBED VACCINE AGAINST FOOT AND MOUTH DISEASE OF SAT-1/NWZ GENOTYPE | 2023 |
|
RU2809219C1 |
CULTURE INACTIVATED SORBED VACCINE AGAINST FOOT AND MOUTH DISEASE FROM A/TANZANIA/2013 STRAIN OF A/AFRICA/G-I GENOTYPE | 2023 |
|
RU2815536C1 |
FMD CULTURE INACTIVATED SORBED VACCINE FROM A/Iran/2018 STRAIN OF A/ASIA/Iran-05 NEW GENOTYPE | 2022 |
|
RU2799605C1 |
CULTURAL INACTIVATED EMULSION VACCINE AGAINST FOOT AND MOUTH DISEASE FROM O NO. 2620/ORENBURGSKY/2021 STRAIN OF O/ME-SA/IND-2001E GENOTYPE | 2023 |
|
RU2815537C1 |
CULTURALLY INACTIVATED SORBED VACCINE AGAINST FOOT AND MOUTH DISEASE OF SAT-2/IV GENOTYPE | 2023 |
|
RU2815541C1 |
CULTURE INACTIVATED ADSORBED VACCINE AGAINST FMD OF SAT-2/VII GENOTYPE FROM SAT-2/ERITREA/1998 STRAIN | 2023 |
|
RU2804875C1 |
STRAIN “O/ARRIAH/MYA-98” OF FOOT AND MOUTH DISEASE VIRUS APHTAE EPIZOOTICAE FOR MANUFACTURING OF BIOLOGICAL PRODUCTS FOR DIAGNOSIS AND SPECIFIC PREVENTION OF FOOT-AND-MOUTH DISEASE | 2023 |
|
RU2811585C1 |
Authors
Dates
2020-06-02—Published
2019-10-01—Filed